We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Philips to Acquire Emergency-Response Firm

By HospiMedica staff writers
Posted on 14 Feb 2006
Print article

In a move intended to improve its position in the expanding home-monitoring market, Philips Medical Systems (Best, The Netherlands) has agreed to buy Lifeline Systems (Framingham, MA, USA) for U.S.$750 million, or five times its 2005 sales.

Lifeline Systems provides emergency-response services for senior citizens and disabled people and has annual sales of $150 million. The deal is the biggest move yet by Philips to expand its consumer-health business. This latest purchase follows last year's acquisition of health-care technology company Stentor for $280 million.

Gerard Kleisterlee, chief executive of Philips Electronics (Amsterdam, Holland), sees higher-margin medical technology and health care as a key area for expansion, helping to make the Dutch company less dependent on volatile businesses such as semiconductors. The consumer-health division seeks to adapt technologies from the medical world and make them consumer friendly. One example is the company's home version of a defibrillator.



Related Links:
Philips Medical Systems
Lifeline Systems
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Bioengineered Collagen Implant
Tapestry Biointegrative Implant
New
Monitor Arm
ITD Flexion

Print article

Channels

Surgical Techniques

view channel
Image: Graphical abstract; Surgical field during endomyocardial biopsy and fluoroscopic images (Photo courtesy of Heart Rhythm, DOI: 10.1016/j.hrthm.2024.10.069)

Novel Method Combining Heart Biopsy and Device Implantation Reduces Complications Risk

Endomyocardial biopsy (EMB) is a crucial diagnostic tool for identifying various cardiac conditions; however, it carries a risk of complications due to its invasive nature. New research has introduced... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.